<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260722070312N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-10-11</date_registration>
      <primary_sponsor>The University of Esfahan</primary_sponsor>
      <public_title>The effect of dual-task exercise on physical and cognitive function in patients with parkinson’s disease.</public_title>
      <acronym></acronym>
      <scientific_title>The effect of multi-component dual-task chair exercises on biochemical, functional, and cognitive indices in multiple parkinsonian patients.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-08-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/91941</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Following the application of inclusion and exclusion criteria, eligible participants were enrolled in the study. Randomization was performed at the individual level using a random number table. Participants were initially listed in alphabetical order and assigned sequential identification numbers. Subsequently, subjects were allocated to one of two groups based on their assigned numbers, where even numbers were assigned to one group and odd numbers to the other, Blinding description: To minimize bias, participants were assigned to two groups based on personal circumstances and determining factors, as well as their level of interest and accessibility. The protocols for both groups were designed to ensure a high degree of similarity regarding the type, duration, and setting of the activities; the only difference was the greater use of cognitive tools in the dual-task training group. The instructor, the person collecting blood samples, the laboratory staff, and the statistician were unaware of the group assignments.</study_design>
      <phase>3</phase>
      <hc_freetext>Parkinson.</hc_freetext>
      <i_freetext>Intervention 1: We have an intervention group, half of the people are in the intervention group. The equipment required for the intervention group was: ball, stick and chair along with music. The duration of the sessions was 3 sessions per week for 8 weeks and the length of each session started from 40 minutes and gradually increased to 60 minutes per session. Intervention 2: Control group: Control group: We have a control group and half of the patients were placed in this group. For the control group, no intervention was done and the people had the same lifestyle as before during our study work and during these eight weeks they followed the same dose of the previous medicine and the same diet as before.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The factors being assessed will be expressed as standard deviation and mean.

When:
The access period begins in the year 1406.

To whom:
Credible statistical methods will be employed, and the findings will be published in scientific research outputs.

Conditions:
We use validated forms from previous scientific studies.

Where to obtain:
Call:09308550524

How to obtain:
The process involves pre-test and post-test evaluations, and since blood samples are involved, it will take approximately six months.

Comments:
marzieh.zamanifaradonbeh2@gmail.com</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Marzieh Zamani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University of Esfahan,Hezarjerib street</address>
        <city>Esfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673441</zip>
        <telephone>+98 31 3793 2128</telephone>
        <email>marziizamaani@gmail.com</email>
        <affiliation>The University of Esfahan</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Marzieh Zamani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University of Esfahan،Hezarjerib street</address>
        <city>Esfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673441</zip>
        <telephone>+98 31 3793 2128</telephone>
        <email>marziizamaani@gmail.com</email>
        <affiliation>The University of Esfahan</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with physician-confirmed mild to moderate disease
Patients should not have a history of participating in any sports program in the past three years
Parkinson's patients should not have other underlying diseases
Before the study begins, the experimental procedures and possible risks should be explained to the participants
The consent form must be signed by the patient or the patient's companion
Patients must be in the age range of 55 to 70</inclusion_criteria>
      <agemin>55 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with a physician-confirmed diagnosis of mild-to-moderate Parkinson’s disease
Patients should have no history of participating in an exercise program during the past three years
Patients should not have any other underlying medical conditions
Prior to the commencement of the study, the experimental procedures and potential risks were fully explained to the participants
The informed consent form was signed by either the participant or their legal representative/caregiver</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G20</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Parkinson's disease</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>We have an intervention group, half of the people are in the intervention group. The equipment required for the intervention group was: ball, stick and chair along with music. The duration of the sessions was 3 sessions per week for 8 weeks and the length of each session started from 40 minutes and gradually increased to 60 minutes per session.</i_keyword>
      <i_keyword>Control group: Control group: We have a control group and half of the patients were placed in this group. For the control group, no intervention was done and the people had the same lifestyle as before during our study work and during these eight weeks they followed the same dose of the previous medicine and the same diet as before.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Biochemical markers are laboratory measurements of body chemical compounds, including levels of brain-derived neurotrophic factor and dopamine. Timepoint: The factors were measured before the start of 8 weeks of training and after the end of eight weeks. Method of measurement: Blood factors were measured using the ELISA method.</prim_outcome>
      <prim_outcome>Functional indices are measures that assess a person's ability to perform physical, motor, or daily activities, including lower body flexibility, cardiorespiratory endurance, dynamic balance, and muscle strength. Timepoint: The factors were measured before the start of 8 weeks of training and after the end of eight weeks. Method of measurement: The sit-and-stand test with a chair to measure lower body flexibility, the six-minute walk test for cardiorespiratory endurance, the timed get-up-and-go test to assess dynamic balance, and the five-repetition sit-to-stand test to assess lower body functional strength ability.</prim_outcome>
      <prim_outcome>Cognitive indices are measures of mental and brain function, including sleep quality and dementia. Timepoint: The factors were measured before the start of 8 weeks of training and after the end of eight weeks. Method of measurement: MOCA questionnaire for assessing dementia, PSQI questionnaire for assessing sleep quality.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The University of Esfahan</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-07-28</approval_date>
        <contact_name>University of Isfahan</contact_name>
        <contact_address>University of Isfahan, Hezar-Jarib Street Esfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
